| Patent application number | Description | Published |
|---|
| 20080242672 | ADENOSINE A2A RECEPTOR ANTAGONISTS - The present invention provides compounds of the formula | 10-02-2008 |
| 20080242673 | ADENOSINE A2A RECEPTOR ANTAGONISTS - The present invention provides compounds of the formula | 10-02-2008 |
| 20090023799 | CRYSTALS OF (2-AMINO-4,5,6,7-TETRAHYDROBENZO[b]THIEN-3-YL)(4-CHLOROPHENYL)METHANONE - The present invention provides crystal forms of (2-amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(4-chlorophenyl)methanone of the formula | 01-22-2009 |
| 20090281145 | ALLOSTERIC ENHANCERS OF THE A1 ADENOSINE RECEPTOR - The present invention provides compounds of formula (I) | 11-12-2009 |
| 20100324279 | CRYSTAL FORMS OF 2-[2-(4-CHLOROPHENYL)ETHOXY]ADENOSINE - The present invention provides novel crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosine of the formula processes for the production of such crystal forms, and methods for the manufacture of pharmaceutical compositions for the treatment of diseases or conditions modulated by the adenosine A2 receptors, in particular the A2A receptor, in a mammal in need thereof, by employing such crystal forms. The crystal forms of the present invention are especially useful in the preparation of topical compositions for accelerating wound healing, e.g., for the treatment of diabetic foot ulcers. | 12-23-2010 |
| 20110044904 | CRYSTAL FORMS OF 2--ADENOSINE - The present invention provides novel crystalline polymorphic forms of 2-cyclohexylmethylidenehydrazino adenosine, also known as binodenoson, methods of making the same, and methods for the manufacture of a pharmaceutical composition by employing such crystal forms, in particular, for the use of binodenoson in a subject, in need thereof, as a pharmacological stress agent to produce coronary vasodilation. | 02-24-2011 |
| 20110053917 | Allosteric Modulators of the A1 Adenosine Receptor - The present invention provides compounds of formula (I) | 03-03-2011 |
